RACK1 and breast cancer: Similarly, OXER1 silencing in MDA-MB-231, a BC cell line that significantly expresses OXER132, causes a significant down-regulation of RACK1 expression due to impairment of the PI3K/Akt/NF-κB pathway (Fig. 5I–M).